Jonasch, E., Hasanov, E., Flynt, L., Tidwell, R. S., Hwang, H., Brooks, R., Wood, L. M., Solley, T., Mack, D., Yamamura, Y., Venkatesan, A. M. (2025). STARLITE-1: Phase 1b/2 study of combination
                    <sup>177</sup>
                    Lu girentuximab plus cabozantinib and nivolumab in treatment naive patients with advanced clear cell RCC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps4611